Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1000
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1000

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postacute sequelae of SARS-CoV-2 infection on ophthalmic diseases: a binational cohort study.

The British journal of ophthalmology·2026
Same author

Factors Associated With Glaucomatous Progression in Eyes With Prior Refractive Corneal Surgery.

Journal of glaucoma·2025
Same author

Subclinical Coronary Atherosclerosis and Retinal Optical Coherence Tomography Angiography.

JAMA cardiology·2025
Same author

Relationship Between Periodontitis and Open Angle Glaucoma: The Korea National Health and Nutrition Examination Survey.

Journal of glaucoma·2025
Same author

Choroidal microvascular dropout and its relationship to progression in primary open-angle and pseudoexfoliation glaucoma.

BMC ophthalmology·2025
Same author

Comparative analysis of the optic nerve microvasculature between different optic disc phenotypes of normal-tension glaucoma patients.

BMC ophthalmology·2025

Related Experiment Video

Updated: Oct 27, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K

Can Artificial Intelligence Predict Glaucomatous Visual Field Progression? A Spatial-Ordinal Convolutional Neural

Kilhwan Shon1, Kyung Rim Sung2, Joong Won Shin3

  • 1From the Department of Ophthalmology (K.S.), Gangneung Asan Hospital, Gangneung, Korea.

American Journal of Ophthalmology
|July 20, 2021
PubMed
Summary
This summary is machine-generated.

Artificial neural networks (NN) using spatial and ordinal data significantly improve prediction of glaucomatous visual field (VF) progression compared to linear models. This advancement aids in earlier detection and management of vision loss.

More Related Videos

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.0K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

618

Related Experiment Videos

Last Updated: Oct 27, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.0K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

618

Area of Science:

  • Ophthalmology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Glaucomatous visual field (VF) progression is a leading cause of irreversible blindness.
  • Accurate prediction of VF progression is crucial for timely intervention and management.
  • Current predictive models have limitations in capturing complex spatial-ordinal patterns of VF changes.

Purpose of the Study:

  • To develop and evaluate an artificial neural network (NN) model for predicting glaucomatous VF progression.
  • To incorporate both spatial and ordinal information within the NN architecture.
  • To compare the predictive performance of NN models against traditional linear models.

Main Methods:

  • A cohort study included 9212 eyes from 6047 primary open-angle glaucoma patients with over 4 years of VF data.
  • Spatial-ordinal tensors were constructed by stacking 3 consecutive VF tests (VF-blocks).
  • Convolutional neural network (NN) models were developed and compared with linear regression and pointwise linear regression (PLR) models using AUROC.

Main Results:

  • The best-performing NN model achieved an AUROC of 0.864 (sensitivity 0.42, specificity 0.95).
  • Linear models, including PLR, showed significantly lower performance (PLR AUROC 0.611).
  • Progression was identified in 5.5% to 10.2% of VF-blocks based on different criteria, with progression groups being older and having worse initial VF indices.

Conclusions:

  • NN models integrating spatial-ordinal characteristics significantly outperform linear models in predicting glaucomatous VF progression.
  • This approach offers a more robust method for identifying patients at risk of vision loss.
  • The findings support the use of advanced AI models for enhanced glaucoma management.